Muco-cutaneous pigmentation and photosensitization induced by minocycline hydrochloride

Journal of Dermatological Treatment

Volumn 10, Issue 2, 1999, Pages 105-112

  Peyriere, H ^a   Hillaire Buys, D ^a   Dereure, O ^b   Meunier, L ^b   Blayac, J P ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Cutaneous pigmentations; Minocycline; Photosensitization

Indexed keywords

IRON; MELANIN; MINOCYCLINE; TETRACYCLINE DERIVATIVE;

ADULT; AGED; ARTICLE; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MOUTH; NAIL; PHOTOSENSITIVITY; PIGMENT DISORDER; PRIORITY JOURNAL; SKIN PIGMENTATION;

EID: 0032772023     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639909056011     Document Type: Article

References (66)

1. Philippon A, Paul G, Giroud JP, Tétracyclines. In: Giroud JP, Mathe G, Meyniel G. Pharmacologie clinique -base de la thérapeutique 2nd edn. Expansion Scientifique Française, Paris 1988, pp 1432-45.
2. Kapusnik-Uner JE, Sande MA, Chambers HF, Antimicrobial agents. In: Goodman & Gilman's The pharmacological basis of therapeutics 9th edn. McGraw-Hill, New York, 1996, pp 1124-30.
3. Hendrix JD, Greer KE, Cutaneous hyperpigmentation caused by systemic drugs, Int J Dermatol (1992) 31: 458-66.
4. Leyden JL, Absorption of minocycline hydrochloride and tetracycline hydrochloride. Effect of food, milk and iron. J Am Acad Dermatol (1985) 12: 308-12.
5. Saivin S, Houin G, Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet (1988) 15: 355-66.
6. Sitbon O et al, Minocycline pneumonitis and eosinophilia: a report on eight patients. Arch Intern Med (1994) 154: 1633-40.
7. Bridges AJ, Graziano FM, Calhoun W, Reizner GT, Hyperpigmentation, neutrophilic alveolitis and erythema nodosum resulting from minocycline. J Am Acad Dermatol (1990) 22: 959-62.
8. Gough A et al, Minocycline-induced autoimmune hepatitis and systemic lupus erythematous-like syndrome. BMJ (1996) 312: 169-72.
9. Thibault MJ, Billick R, Srolovitz H, Minocycline-induced sweet syndrome. J Am Acad Dermatol (1992) 27: 801-4.
10. Gordon P et al, Minocycline-associated lupus erythematosus. Br J Dermatol (1995) 132: 120-1.
11. Puyana J et al, Serum sickness-like syndrome associated with minocycline therapy. Allergy (1990) 45: 313-15.
12. Knowles SR, Shapiro L, Shear NH, Serious adverse reactions induced by minocycline. Arch Dermatol (1996) 132: 934-9.
13. Basler RSW, Kohnen PW, Localised hemosiderosis as a sequela of acne. Arch Dermatol (1978) 114: 1695-7.
14. Fenske NA, Millns JL, Greer KE, Mynocyclin induced pigmentation at sites of cutaneous inflammation. JAMA (1980) 244: 1103-16.
15. 5. McGrae JD, Zelickson AS, Skin pigmentation secondary to minocycline therapy. Arch Dermatol (1980) 116: 1262-5.
16. Simons JJ, Morales A, Minocycline and generalized cutaneous pigmentation. J Am Acad Dermatol (1980) 3: 244-7.
17. Leroy JP et al, Deux cas de pigmentation cutanée au cours de traitements par la minocycline. Ann Dermatol Venereol (1981) 108: 871-5.
18. Ridgway HA et al, Hyperpigmentation associated with oral minocycline. Br J Dermatol (1982) 107: 95-102.
19. Rogers SCF, McCabe MMM, Skin pigmentation due to minocycline therapy for acne vulgaris. Br J Dermatol (1983) suppl 26, 59-61.
20. Verret JL et al, Pigmentation cutanée induite par la minocycline. Ann Dermatol Venéréol (1983) 110: 777-8.
21. Zijdenbos AM, Balmus KJ, Pigmentation secondary to minocycline therapy. Br J Dermatol (1984) 110: 117-18.
22. Basler RSW, Minocycline-related Hyperpigmentation. Arch Dermatol (1985) 121: 606-8.
23. Prigent F, Cavelier-Balloy B, Tollenaere C, Civatte J, Pigmentation cutanée induite par la minocycline: deux cas. Ann Dermatol Vénéréol (1986) 113: 227-33.
24. Shum DT, Smout MS, Pace WE, Headington JT, Unusual skin pigmentation from long-term methacycline and minocycline therapy. Arch Dermatol (1986) 122: 17-18.
25. Argenyi ZB et al, Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and X-ray energy spectroscopy. J Cutan Pathol (1987) 14: 176-80.
26. Bamberger N, Guillaume JC, Avril MF, Quel est votre diagnostic? Ann Dermatol (1990) 117: 299-300.
27. Eedy D, Burrows D, Minocycline-induced pigmentation occurring in two sisters. Clin Exp Dermatol (1991) 16: 55-7.
28. Leffell DJ, Minocycline hydrochloride hyperpigmentation complicating treatment of venous ectasia of extremities. J Am Acad Dermatol (1991) 24: 501-2.
29. Moritz DL, Elewski B, Pigmented postacne osteoma cutis in a patient treated by minocycline. Report and review of the literature. J Am Acad Dermatol (1991) 24: 851-3.
30. Fakhfakh AC et al, Pigmentation cutanée, induite par la minocycline: étude ultrastructurale et micro-analyse aux rayons X. Ann Dermatol Venereol (1992) 119: 975-9.
31. Ridgway HB, Reizner GT, Acquired pseudo-mongolian spot associated with minocycline therapy. Arch Dermatol (1992) 128: 565-6.
32. Vanhooteghem O et al, Pigmentation cutanée induite par la minocycline. Nouv Dermatol (1992) 11: 415-18.
33. Pepine M, Flowers FP, Ramos-Caro FA, Extensive cutaneous hyperpigmentation caused by minocycline. J Am Acad Dermatol (1993) 28: 292-5.
34. Chu P, Van SL, Yen TSB, Berger TG, Minocycline hyperpigmentation localized to the lips: An unusual fixed drug reaction? J Am Acad Dermatol (1994) 30: 802-3.
35. Basset-Seguin N et al, Pigmentation cutanée à la minocycline: à propos d'un cas. Nouv Dermatol (1995) 14: 34-5.
36. Hung PH, Caldwell JB, James WD, Minocycline-induced hyperpigmentation. J Fam Pract (1995) 41: 183-5.
37. Meyer AJ, Nahass GT, Hyperpigmented patches on the dorsa of the feet. Arch Dermatol (1995) 131: 1447.
38. Layton AM, Cunliffe WJ, Minocycline induced pigmentation in the treatment of acne - a review and personal observations. J Dermatol Treat (1989) 1: 9-12.
39. Dwyer CM et al, Skin pigmentation due to minocycline treatment of facial dermatoses. Br J Dermatol (1993) 129: 158-62.
40. Goulden V, Glass D, Cunliffe WJ, Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol (1996) 134: 693-5.
41. Eisen D, Minocycline-induced oral hyperpigmentation. Lancet (1997) 349: 400.
42. Frost P, Weinstein GD, Gomez EC, Phototoxic potential of minocycline and doxycycline. Arch Dermatol (1972) 105: 681-4.
43. Begaud B, Evreux JC, Jouglard J, Lagier G, Unexpected or toxic drug reaction assessment (imputation). Actualization of the method used in France. Thérapie (1985) 40: 115-18.
44. Odell EW, Hodgson RP, Haskell R, Oral presentation of minocycline-induced black bone disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 79: 459-61.
45. Shea CR et al, Phototoxicity of lumidoxycycline. J Invest Dermatol (1993) 101: 329-33.
46. Jolly HW et al, Fixed drug eruptions to tetracydines. Arch Dermatol (1978) 114: 1484-5.
47. Sato S et al, Ultrastructural and X-ray microanalytical observations of minocycline related hyperpigmentation of the skin. J Invest Dermatol (1981) 77: 264-71.
48. Meyerson MA, Cohen PR, Hymes SR, Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol (1995) 79: 180-4.
49. Siller GM, Tod MA, Savage NW, Minocycline induced oral pigmentation. J Am Acad Dermatol (1994) 30: 350-4.
50. Berger RS, Mandel EB, Hayes TJ, Grimwood RR, Minocycline staining of the oral cavity. J Am Acad Dermatol (1989) 21: 1300-1.
51. Caro I, Discoloration of the teeth related to minocycline therapy for acne. J Am Acad Dermatol (1980) 3: 317-18.
52. Sabroe RA et al, Minocycline-induced discolouration of the sclerae. Br J Dermatol (1996) 135: 314-16.
53. Brothers DM, Hidayat AA, Conjunctival pigmentation associated with tetracycline medication. Ophthalmology (1981) 88: 1212-15.
54. Messmer E, Font RL, Sheldon G, Murphy D, Pigmented conjunctival cysts following tetracycline/minocycline therapy. Ophthalmology (1983) 90: 1462-8.
55. Mallon E, Dawber RPR, Longitudinal melanonychia induced by minocycline. Br J Dermatol (1994) 130: 794-5.
56. Wolfe ID, Reichmister J, Minocycline hyperpigmentation: skin, tooth, nail and bone involvement. Cutis (1984) 33: 457-8.
57. White SW, Besanceney C, Systemic pigmentation from tetracycline and minocycline therapy. Arch Dermatol (1983) 119: 1-2.
58. Landas SK et al, Black thyroid syndrome: exaggeration of a normal process? AJPC (1996) 85: 411-8.
59. Basler RSW, Lynch PJ, Black galactorrhea as a consequence minocycline and phenothiazine therapy. Arch Dermatol (1985) 121: 417-18.
60. Hunt MJ, Salisbury ELC, Grace J, Armati R, Black breast milk due to minocycline therapy. Br J Dermatol (1996) 134: 943-4.
61. Butt A, Das KB, Statham BN, Minocycline-induced pigmentation of basal cell carcinomas. J Dermatol Treat (1998) 9: 39-40.
62. Okada N et al, Skin pigmentation associated with minocycline therapy. Br J Dermatol (1989) 121: 247-54.
63. Basler RSW, Goetz CS, Synergism of minocycline and amitriptyline in cutaneous hyperpigmentation. J Am Acad Dermatol (1985) 12: 577.
64. Fleming CJ et al, Minocycline-induced hyperpigmentation in leprosy. Br J Dermatol (1996) 134: 784-7.
65. Gordon G, Sparano BM, Iatropoulos MJ, Hyperpigmentation of the skin associated with minocycline therapy. Arch Dermatol (1985) 121: 618-23.
66. Okada N et al, Characterization of pigmented granules in minocycline-induced cutaneous pigmentation: observations using fluorescence microscopy and high-performance liquid chromatography. Br J Dermatol (1993) 129: 403-7.